CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
Experimental System: MyoVoice +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04762043
NCT04762043N/ACompleted
CompareCT.gov

EMG Voice Restoration

Altec Inc.·interventional·Posted Feb 21, 2021·Updated Sep 23, 2024

In Brief

A clinical study evaluating Experimental System: MyoVoice and Reference System: Electrolarynx for Rehabilitation of Speech and Language Disorders and 5 related conditions. Completed, enrolled 30 participants across 1 site.

Detailed Summary

This study will evaluate the ability of MyoVoice to replace natural speech. Referred to generally as an Augmentative and Alternative Communication (AAC) device, MyoVoice uses electrical signals recorded non-invasively from speech muscles (electromyographic, or EMG, signals) to restore communication for those with vocal impairments that resulted from surgical treatment of laryngeal and oropharyngeal cancers.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRehabilitation of Speech and Language Disorders, Speech Disorders, Speech, Alaryngeal, Communication Aids for Disabled, Speech Perception, Speech Intelligibility
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedFeb 21, 2021
Enrollment StartFeb 12, 2021
Primary CompletionNov 8, 2023
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 5.4 years ago

Interventions

Experimental System: MyoVoicedevice

Person-centric augmentative and alternative communication (AAC) system comprising a user-specific set of wearable sensors for capturing articulatory muscle activity and mobile software that provides real-time audible speech outputs.

Reference System: Electrolarynxdevice

Hand-operated electromechanical device that operates as an artificial larynx to enable a person after laryngectomy to produce speech.